High-throughput Single Cell Co-assay of Histone Modifications andTranscriptome
High-throughput Single Cell Co-assay of Histone Modifications andTranscriptome
批准号:
10698374
负责人:
Christopher Hartl
金额:
$113.31万
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-07-03 至 2025-06-30
关键词:
AddressAdoptionAntibodiesArchitectureAutomationBar CodesBindingBioinformaticsBiologicalBiological AssayBiopsyCancerousCell NucleusCellsChemicalsChromiumChromosomesCollectionComputer softwareContract ServicesCustomDNADNA CrosslinkingDNA MethylationDNA-Binding ProteinsDataData AnalysesData SetDiseaseEnsureEpigenetic ProcessEquipmentGene ExpressionGene Expression ProfileGene Expression RegulationGenesGenetic FingerprintingsGenetic MaterialsGenetic TranscriptionGoalsHeritabilityHeterogeneityHourImageIndividualInformaticsInfrastructureIntestinesInvestmentsJointsLaboratoriesLaboratory ResearchLibrariesManagement Information SystemsManualsMemoryMethodologyMethodsMicrofluidicsMolecularMonitorNeuronsNuclearOrganismPerformancePermeabilityPersonsPhasePopulationPreparationProtocols documentationPublishingReagentRegulator GenesRegulatory ElementRenal TissueReproducibilityResearchResearch InstituteRunningSamplingScanningServicesSignal TransductionSmall Business Innovation Research GrantSystemTechnologyTestingTissue SampleTissuesTn5 transposaseTubeWorkanalysis pipelinecell typechromatin immunoprecipitationcombinatorialcomputerized data processingcostcrosslinkdata complexitydesigndevelopmental diseaseepigenetic profilingepigenomeexperimental studyhistone modificationhuman errorimprovedinsightmultiple omicsnew technologynext generationpreservationprogramsprotein expressionrelational databasesegregationsingle cell technologytooltranscription factortranscriptome sequencingtumortumorigenesisvirtualweb site
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Summary
Disruption of gene regulation is a major causal factor in heritable disease, developmental disorders,
and oncogenesis. While chromatin immunoprecipitation followed by sequencing (ChIP-seq) and Tn5-
transposase based tagging (Cut&Tag) enable analysis of transcription factor binding and epigenetic state
profiling in bulk tissue samples and tumor biopsies, they produce only population average signals. Yet
regulatory networks and perturbations are heterogeneous between cell classes and types. Single-cell
technologies can overcome the challenge of cellular heterogeneity and provide deeper insight into cell
type-specific gene regulatory programs in healthy, diseased, and cancerous tissues. In prior work, we
developed a single-cell joint assay of histone modification and RNA expression (Paired-Tag), enabling
cell-type-stratified epigenetic profiling from bulk samples. This technology has attracted customers in
both academic and nonprofit research. In the proposed study, we will develop automated protocols and
effect laboratory informatics systems to establish a Paired-Tag services laboratory, we will refine our
protocol to improve experimental throughput and reduce cost, and we will develop a Paired-Tag “TF”
protocol for profiling transcription factor binding profiles. If successful, the research would enable next-
generation multi-omic analysis of tumor or disease samples at comparable cost to single-omic
technologies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Single-cell Epigenome Analysis of the Alzheimer's Disease Brain
-
批准号:10546522
-
项目类别:
-
资助金额:$49.95万
-
财政年份:2022
-
负责人:Christopher Hartl
-
依托单位:
海外基金